• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类白细胞抗原II类阳性的人角膜上皮细胞激活同种异体T细胞。

Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells.

作者信息

Iwata M, Yagihashi A, Roat M I, Zeevi A, Iwaki Y, Thoft R A

机构信息

Department of Ophthalmology, University of Pittsburgh School of Medicine, Pennsylvania.

出版信息

Invest Ophthalmol Vis Sci. 1994 Nov;35(12):3991-4000.

PMID:7960581
Abstract

PURPOSE

To achieve a better understanding of the mechanism of corneal immune diseases, including corneal allograft rejection, the authors examined the potential of human corneal epithelial (HCE) cells to activate allogeneic T lymphocytes.

METHODS

The mixed lymphocyte-HCE cell reaction (MLCER) was performed as follows: HCE cells from primary cultures, with or without treatment with interferon-gamma (IFN-gamma), were treated with mitomycin C and then mixed with peripheral blood lymphocytes (PBL) from normal volunteers. Triplicate cultures were incubated for 7 days. Interleukin-1-alpha (IL-1-alpha) was added to some cultures to examine its effect on MLCER: The lymphocyte responses were measured by 3H-thymidine uptake for the last 18 hours of incubation in MLCER:

RESULTS

IFN-gamma-treated, HLA-class-II-bearing HCE cells stimulated allogenic lymphocytes, whereas IFN-gamma nontreated, class-II-negative HCE cells did not. The stimulation by IFN-gamma-treated HCE cells was blocked by anti-HLA class II monoclonal antibody. In addition, exogenous IL-1-alpha reduced the lymphocyte response in MLCER: This effort was inhibited by indomethacin.

CONCLUSIONS

This study demonstrates that HLA-class-II-bearing HCE cells can activate allogeneic PBL by a major histocompatibility complex class II-dependent mechanism. In addition, HCE cells may regulate immune reactions, probably through prostaglandin production caused by IL-1.

摘要

目的

为了更好地理解角膜免疫疾病的机制,包括角膜移植排斥反应,作者研究了人角膜上皮(HCE)细胞激活同种异体T淋巴细胞的潜力。

方法

混合淋巴细胞 - HCE细胞反应(MLCER)按以下方式进行:来自原代培养的HCE细胞,无论是否用γ干扰素(IFN-γ)处理,先用丝裂霉素C处理,然后与正常志愿者的外周血淋巴细胞(PBL)混合。一式三份的培养物孵育7天。将白细胞介素-1-α(IL-1-α)添加到一些培养物中以检查其对MLCER的影响:在MLCER孵育的最后18小时通过3H-胸腺嘧啶核苷摄取测量淋巴细胞反应。

结果

经IFN-γ处理、携带HLA-II类分子的HCE细胞刺激同种异体淋巴细胞,而未经IFN-γ处理、II类阴性的HCE细胞则不能。经IFN-γ处理的HCE细胞的刺激被抗HLA II类单克隆抗体阻断。此外,外源性IL-1-α降低了MLCER中的淋巴细胞反应:这种作用被吲哚美辛抑制。

结论

本研究表明,携带HLA-II类分子的HCE细胞可通过主要组织相容性复合体II类依赖性机制激活同种异体PBL。此外,HCE细胞可能通过IL-1引起的前列腺素产生来调节免疫反应。

相似文献

1
Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells.人类白细胞抗原II类阳性的人角膜上皮细胞激活同种异体T细胞。
Invest Ophthalmol Vis Sci. 1994 Nov;35(12):3991-4000.
2
Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon-gamma.干扰素-γ对培养的角膜上皮细胞上HLA II类抗原表达的调节
Invest Ophthalmol Vis Sci. 1992 Aug;33(9):2714-21.
3
Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.经干扰素-γ处理的成纤维细胞对缺陷性抗原呈递的剖析
J Immunol. 1987 Jan 15;138(2):385-92.
4
Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.人成纤维细胞在丝裂原刺激的T淋巴细胞产生γ干扰素中的辅助功能。白细胞介素1和肿瘤坏死因子的抑制作用。
J Immunol. 1987 Nov 15;139(10):3330-7.
5
Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.与活化的T细胞和抗原共培养的施万细胞在未进行γ干扰素预处理的情况下表达主要组织相容性复合体(MHC)II类决定簇:γ干扰素和肿瘤坏死因子对MHC II类诱导的协同作用。
Eur J Immunol. 1989 Jan;19(1):177-83. doi: 10.1002/eji.1830190128.
6
A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-gamma.人角膜成纤维细胞的一种可溶性产物可抑制淋巴细胞活化。γ干扰素可增强这种抑制作用。
Exp Eye Res. 1993 Feb;56(2):157-65. doi: 10.1006/exer.1993.1023.
7
The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.人胎儿视网膜色素上皮的免疫原性潜能及其与移植的关系。
Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2662-71.
8
Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.经干扰素-γ处理的内皮细胞和成纤维细胞的抗原呈递:尽管Ia表达相当,但作为抗原呈递细胞发挥功能的能力存在差异。
J Immunol. 1985 Dec;135(6):3750-62.
9
Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.培养的淋巴细胞与人血管内皮细胞黏附的机制。T淋巴细胞通过γ干扰素诱导的内皮细胞HLA - DR抗原与内皮细胞黏附。
J Clin Invest. 1986 May;77(5):1596-605. doi: 10.1172/JCI112475.
10
Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells.人内皮细胞的同种异体抗原性。1. 可对同种异体内皮细胞产生反应的人辅助性T淋巴细胞的频率和表型。
J Immunol. 1992 Jun 15;148(12):3753-60.

引用本文的文献

1
A Human Corneal Epithelial Cell Line Model for Limbal Stem Cell Biology and Limbal Immunobiology.人角膜上皮细胞系在角膜缘干细胞生物学和角膜缘免疫生物学中的应用。
Stem Cells Transl Med. 2017 Mar;6(3):761-766. doi: 10.5966/sctm.2016-0175. Epub 2016 Oct 14.
2
Concise review: immunological properties of ocular surface and importance of limbal stem cells for transplantation.简明综述:眼表面的免疫学特性和角膜缘干细胞移植的重要性。
Stem Cells Transl Med. 2013 Aug;2(8):614-24. doi: 10.5966/sctm.2012-0143. Epub 2013 Jul 1.
3
Ocular surface epithelium induces expression of human mucosal lymphocyte antigen (HML-1) on peripheral blood lymphocytes.
眼表上皮细胞诱导外周血淋巴细胞表达人类黏膜淋巴细胞抗原(HML-1)。
Br J Ophthalmol. 2004 Feb;88(2):280-5. doi: 10.1136/bjo.2003.017731.
4
Intercellular adhesion molecule-1 expression on human corneal epithelial outgrowth from limbal explant in culture.体外培养的角膜缘外植体来源的人角膜上皮细胞中细胞间黏附分子-1的表达
Br J Ophthalmol. 2003 Feb;87(2):203-7. doi: 10.1136/bjo.87.2.203.